Source: Eur Respir J 2011; 37: 1083-1090
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cooley J., Sontag M.K., Accurso F.J., Remold-O'Donnell E.. SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition. Eur Respir J 2011; 37: 1083-1090

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Source: Eur Respir J 2004; 23: 620-628 Year: 2004 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis Source: Eur Respir J 2015; 46: 384-394 Year: 2015 Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights Source: Eur Respir J 2009; 33: 475-488 Year: 2009 Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema Source: Eur Respir J 2002; 19: 1050-1057 Year: 2002 A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 Increased detection of interleukin-;5 in sputum by addition of protease inhibitors Source: Eur Respir J 2001; 18: 685-691 Year: 2001 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Cathepsins in bleomycin-induced lung injury in rat Source: Eur Respir J 2003; 22: 427-435 Year: 2003 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Inhaled heparin in cystic fibrosis Source: Eur Respir J 2006; 27: 354-358 Year: 2006 Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Type II transmembrane serine protease matriptase is a mediator of pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003 17β-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010